Rydapt has actually been demonstrated to enhance survival in sufferers with AML connected with an FLT3 mutation. One most important review, involving 717 these individuals, compared Rydapt with placebo (a dummy treatment) in the beginning being an addition to other most cancers medicines, followed by procedure with Rydapt or placebo alone in Those